dorsaVi (ASX: $DVL) appoints Mathew Regan as Group CEO, effective Nov 1, 2025.
Former CEO of Artrya (ASX: AYA), Regan brings deep expertise in AI, digital health, and advanced manufacturing with a proven track record in scaling global platforms.
Comes at a pivotal time as $DVL advances RRAM, AI & robotics commercialisation.
Link to the Announcement: Click Here